Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
ALX Oncology Holdings
(NASDAQ:ALXO)
Intraday
$14.21
-0.45
[-3.07%]
After-Hours
$14.21
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$14.21
-0.45
[-3.07%]
At close: May 17
$14.21
0
[0.00%]
After Hours: 4:00PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for ALX Oncology Holdings Stock (NASDAQ:ALXO)
ALX Oncology Holdings Stock (NASDAQ: ALXO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, May 09, 2024
ALX Oncology Holdings Q1 EPS $(0.71)
Benzinga Newsdesk
-
May 9, 2024, 4:36PM
Tuesday, April 30, 2024
ALX Oncology Announces Initiation Of Phase 2 Investigator-Sponsored Trial Of Neoadjuvant RadiationAand Evorpacept In Combination With Pembrolizumab In Patients With Untreated HPV-Mediated Oropharyngeal Cancer
Benzinga Newsdesk
-
Apr 30, 2024, 9:12AM
Wednesday, April 17, 2024
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Apr 17, 2024, 1:36PM
United Airlines Reports Upbeat Results, Joins Children's Place, Interactive Brokers And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
-
Apr 17, 2024, 10:55AM
Friday, April 12, 2024
Cantor Fitzgerald Reiterates Overweight on ALX Oncology Holdings
Benzinga Newsdesk
-
Apr 12, 2024, 9:42AM
Wednesday, April 10, 2024
HC Wainwright & Co. Reiterates Buy on ALX Oncology Holdings, Maintains $20 Price Target
Benzinga Newsdesk
-
Apr 10, 2024, 11:18AM
Tuesday, April 09, 2024
ALX Oncology Reports Clinical Data From Ongoing Phase 1/2 Investigator-Sponsored Trial Of Evorpacept In Combination With R2 In Patients With Indolent And Aggressive R/R B-NHL
Benzinga Newsdesk
-
Apr 9, 2024, 5:35PM
Monday, March 11, 2024
HC Wainwright & Co. Maintains Buy on ALX Oncology Holdings, Raises Price Target to $20
Benzinga Newsdesk
-
Mar 11, 2024, 6:39AM
Friday, March 08, 2024
ALX Oncology Has 'Elevated Valuation' - Analyst Downgrades Stock, Highlights Need For Development De-Risking Beyond Gastric Cancer
Vandana Singh
-
Mar 8, 2024, 1:48PM
ALX Oncology shares are trading lower after the company reported Q4 financial results. Following earnings, Stifel downgraded the stock from Buy to Hold.
Benzinga Newsdesk
-
Mar 8, 2024, 8:37AM
Piper Sandler Maintains Overweight on ALX Oncology Holdings, Raises Price Target to $21
Benzinga Newsdesk
-
Mar 8, 2024, 8:29AM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Mar 8, 2024, 8:09AM
Stifel Downgrades ALX Oncology Holdings to Hold, Raises Price Target to $14
Benzinga Newsdesk
-
Mar 8, 2024, 4:26AM
Thursday, March 07, 2024
ALX Oncology Holdings Q4 2023 GAAP EPS $(0.930) Misses $(0.860) Estimate
Benzinga Newsdesk
-
Mar 7, 2024, 4:22PM
Tuesday, March 05, 2024
ALX Oncology Announces Two Evorpacept Clinical Abstracts Accepted For Presentation At The AACR Annual Meeting
Benzinga Newsdesk
-
Mar 5, 2024, 4:33PM
Friday, December 22, 2023
Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
-
Dec 22, 2023, 1:28PM
Karuna Therapeutics Jumps Following Takeover By Bristol Myers, Joins Rocket Lab USA, Altair Engineering And Other Big Stocks Moving Higher On Friday
Avi Kapoor
-
Dec 22, 2023, 11:20AM
Friday, December 08, 2023
Why Comtech Telecommunications Shares Are Trading Lower By Over 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
-
Dec 8, 2023, 12:57PM
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Dec 8, 2023, 12:31PM
ALX Oncology shares are trading higher after Jefferies upgraded the stock from Hold to Buy and raised its price target from $8 to $18.
Benzinga Newsdesk
-
Dec 8, 2023, 10:45AM
Torrid Reports Upbeat Results, Joins MBIA, Virco Mfg. And Other Big Stocks Moving Higher On Friday
Avi Kapoor
-
Dec 8, 2023, 10:40AM
Where ALX Oncology Holdings Stands With Analysts
Benzinga Insights
-
Dec 8, 2023, 10:00AM
Jefferies Upgrades ALX Oncology Holdings to Buy, Raises Price Target to $18
Benzinga Newsdesk
-
Dec 8, 2023, 6:27AM
Tuesday, November 14, 2023
The Latest Analyst Ratings for ALX Oncology Holdings
Benzinga Insights
-
Nov 14, 2023, 1:01PM
Stifel Maintains Buy on ALX Oncology Holdings, Lowers Price Target to $10
Benzinga Newsdesk
-
Nov 14, 2023, 12:51PM
Monday, November 13, 2023
ALX Oncology Holdings Q3 EPS $(1.24) Misses $(0.87) Estimate
Benzinga Newsdesk
-
Nov 13, 2023, 5:15PM
Wednesday, October 11, 2023
Piper Sandler Maintains Overweight on ALX Oncology Holdings, Raises Price Target to $11
Benzinga Newsdesk
-
Oct 11, 2023, 11:36AM
Friday, October 06, 2023
ALX Oncology Holdings Shares Resume Trade
Benzinga Newsdesk
-
Oct 6, 2023, 3:07PM
ALX Oncology Holdings Shares Halted On Circuit Breaker To The Upside, Stock Now Up 34.7%
Benzinga Newsdesk
-
Oct 6, 2023, 3:04PM
Thursday, October 05, 2023
What's Going On With ALX Oncology Stock?
Henry Khederian
-
Oct 5, 2023, 10:33AM
ALX Oncology Has Priced Its Underwritten Public Offering Of Common Stock And Pre-funded Warrants. The Company Is Selling 7.37M Shares At $6.38/Share And Pre-funded Warrants To Purchase 1.25M Shares At $6.379/Pre-funded Warrant, With Gross Proceeds Of $55M
Benzinga Newsdesk
-
Oct 5, 2023, 8:07AM
Wednesday, October 04, 2023
ALX Oncology Holdings Reported ~ $196.5M Of Cash, Cash Equivalents And Short-term And Long-term Investments As Of September 30, 2023.
Charles Gross
-
Oct 4, 2023, 5:27PM
ALX Oncology Announces Proposed Public Offering; Terms Not Disclosed
Benzinga Newsdesk
-
Oct 4, 2023, 4:12PM
The Latest Analyst Ratings for ALX Oncology Holdings
Benzinga Insights
-
Oct 4, 2023, 1:00PM
Why Cal-Maine Foods Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
-
Oct 4, 2023, 12:48PM
UBS Maintains Buy on ALX Oncology Holdings, Lowers Price Target to $27
Benzinga Newsdesk
-
Oct 4, 2023, 11:57AM
Cantor Fitzgerald Maintains Overweight on ALX Oncology Holdings, Raises Price Target to $23
Benzinga Newsdesk
-
Oct 4, 2023, 10:07AM
Cal-Maine Foods, A10 Networks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Lisa Levin
-
Oct 4, 2023, 6:08AM
Tuesday, October 03, 2023
Crude Oil Moves Higher; POINT Biopharma Global Shares Jump
Lisa Levin
-
Oct 3, 2023, 2:36PM
Why Getty Images Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
-
Oct 3, 2023, 1:32PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Oct 3, 2023, 1:31PM
Wall Street Sell-Off Worsens, VIX Spikes As Bond Yields Rise Further, Dollar Strengthens: What's Driving Markets Tuesday?
Shanthi Rexaline
-
Oct 3, 2023, 1:26PM
HC Wainwright & Co. Reiterates Buy on ALX Oncology Holdings, Raises Price Target to $17.5
Benzinga Newsdesk
-
Oct 3, 2023, 12:07PM
'Airbnb Has Foundational Cracks', Disney+ Follows Netflix On Subscription Sharing Crackdown, Microsoft's Nadella Criticizes Google's Exclusive Content Deals: Today's Top Stories
Vandana Singh
-
Oct 3, 2023, 10:11AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Oct 3, 2023, 9:06AM
Why Cancer-Focused ALX Oncology Stock Gained Over 100% Today?
Vandana Singh
-
Oct 3, 2023, 8:58AM
Market-Moving News for October 3rd
Benzinga Newsdesk
-
Oct 3, 2023, 8:40AM
Why Delta Apparel Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Oct 3, 2023, 8:02AM
ALX Oncology shares are trading higher after the company released interim Phase 2 data from its ASPEN-06 trial of evorpacept in advanced HER2-positive gastric cancer.
Benzinga Newsdesk
-
Oct 3, 2023, 6:56AM
ALX Oncology Reports Interim Phase 2 ASPEN-06 Trial Data For Advanced HER2-Positive Gastric Cancer, Showing Confirmed Overall Response Rate Of 52% For Evorpacept Combo Treatment Versus 22% For Control Treatment
Benzinga Newsdesk
-
Oct 3, 2023, 6:02AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch